Effect of administration timing of postchemotherapy granulocyte colony-stimulating factor on host-immune cell recovery and CD8⁺ T-cell response

References

• Demetri GD, Griffin JD. 1991. Granulocyte colony-stimulating factor and its receptor. Blood. 78:2791–2808.
   PubMed Web of Science ®Google Scholar
• Ferrari S, Rovati B, Porta C, Alessandrino P, Bertolini A, Collova E, Riccardi A, Danova M. 2003. Lack of dendritic cell mobilization into peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor. Cancer Immunol Immunother. 52:359–366.
   PubMed Web of Science ®Google Scholar
• Franzke A, Piao W, Lauber J, Gatzlaff P, Konecke C, Hansen W, Schmitt-Thomsen A, Hertenstein B, Buer J, Ganser A. 2003. G-CSF as immune regulator in T-cells expressing G-CSF receptor: Implications for transplantation and autoimmune diseases. Blood. 102:734–739.
   PubMed Web of Science ®Google Scholar
• Gattinoni L, Finkelstein S, Klebanoff C, Antony P, Palmer D, Spiess P, Hwang L, Yu Z, Wrzesinski C, Heimann D, et al. 2005. Removal of homeostatic cytokine sinks by lympho-depletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T-cells. J Exp Med. 202:907–912.
   PubMed Web of Science ®Google Scholar
• Gattinoni L, Powell DJ, Rosenberg S, Restifo NP. 2006. Adoptive immunotherapy for cancer: Building on success. Nat Rev Immunol. 6:383–393.
   PubMed Web of Science ®Google Scholar
• Ghiringhelli F, Larmonier N, Schmitt E, Parcellier A, Cathelin D, Garrido C, Chauffert B, Solary E, Bonnotte B, Martin F. 2004. CD4+CD25+ regulatory T-cells suppress tumor immunity but are sensitive to cyclophosphamide that allows immunotherapy of established tumors to be curative. Eur J Immunol. 34:336–344.
   PubMed Web of Science ®Google Scholar
• Liu F, Wu H, Wesselschmidt R, Kornaga T, Link D. 1996. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity. 5:491–501.
   PubMed Web of Science ®Google Scholar
• Lutsiak M, Semnani R, De Pascalis R, Kashmiri S, Schlom J, Sabzevari H. 2005. Inhibition of CD4+CD25+ T-regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood. 105:2862–2868.
   PubMed Web of Science ®Google Scholar
• Montgomery M, Cottler-Fox M. 2007. Mobilization and collection of autologous hematopoietic progenitor/stem cells. J Clin Adv Hematol Oncol. 5:127–123.
   PubMedGoogle Scholar
• Morikawa K, Morikawa S, Nakamura M, Miyawaki T. 2002. Characterization of granulocyte colony-stimulating factor receptor expressed on human lymphocytes. Br J Hematol. 118:296–304.
   PubMed Web of Science ®Google Scholar
• Nervi B, Link D, Di Persio J. 2006. Cytokines and hematopoietic stem cell mobilization. J Cell Biochem. 99:690–705.
   PubMed Web of Science ®Google Scholar
• Paulos C, Wrzesinski C, Kaiser A, Hinrichs C, Chieppa M, Cassard L, Palmer D, Boni A, Muranski P, Yu Z, et al. 2007. Microbial translocation augments function of adoptively transferred self/tumor-specific CD8+ T-cells via TLR4 signaling. J Clin Invest. 117:2197–2204.
   PubMed Web of Science ®Google Scholar
• Rubinstein M, Salem M, Doedens A, Moore C, Chiuzan C, Rivell G, Cole D, Goldrath A. 2013. G-CSF/anti-G-CSF antibody complexes drive potent recovery and expansion of CD11b+Gr-1+ myeloid cells without compromising CD8+ T-cell immune responses. J Hematol Oncol. 1:6–75.
   Google Scholar
• Salem M, Kadima A, El-Naggar S, Rubinstein M, Chen Y, Gillanders WE, Cole D. 2007. Defining the ability of cyclophosphamide pre-conditioning to enhance antigen-specific CD8+ T-cell response to peptide vaccination: Creation of a beneficial host microenvironment involving type I IFN and myeloid cells. J Immunother. 30:40–53.
   PubMed Web of Science ®Google Scholar
• Salem M, Diaz-Montero C, Al-Khami A, El-Naggar S, Naga O, Montero A, Khafagy A, Cole D. 2009. Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells that can mediate enhanced prime-boost vaccination anti-tumor responses in vivo when stimulated with TLR3 agonist poly(I:C). J Immunol. 182:2030–2040.
   PubMed Web of Science ®Google Scholar
• Salem M, Al-Khami A, El-Naggar S, Diaz-Montero C, Chen Y, Cole D. 2010. Cyclophos-phamide induces dynamic alterations in host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cells. J Immunol. 184:1737–1747.
   PubMed Web of Science ®Google Scholar
• Welte K, Bonilla M, O'reilly R, Souza L. 1987. Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med. 165:941–948.
   PubMed Web of Science ®Google Scholar
• Winkler I, Levesque J. 2006. Mechanisms of hematopoietic stem cell mobilization: When innate immunity assails cells that make blood and bone. Exp Hematol. 34:996–1009.
   PubMed Web of Science ®Google Scholar
• Wrzesinski C, Paulos C, Gattinoni L, Palmer D, Kaiser A, Yu Z, Rosenberg S, Nicholas P, Restifo N. 2007. Hematopoietic stem cells promote the expansion and function of adoptively transferred anti-tumor CD8 T-cells. J Clin Invest. 117:492–501.
   PubMed Web of Science ®Google Scholar
• Yankelevich M, Goodell M, Kaplan J. 2008. Efficacy of delayed administration of post-chemo-therapy granulocyte colony-stimulating factor: evidence from murine studies of bone marrow cell kinetics. Exp Hematol. 36:9–16.
   PubMed Web of Science ®Google Scholar
• Yu J, Wheeler C, Zeltzer P, Ying H, Finger D, Lee P, Yong W, Incardona F, Thompson R, Ridinger M, et al. 2001. Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res. 1:842–847.
   Google Scholar